Mikel Musatadi

Mr. Mikel Musatadi

University of the Basque Country UPV/EHU, Bilbao, Biscay, Spain

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Science of The Total Environment
Verified
Journal Article
Closed access
MMMikel Musatadi
Mikel Musatadi
BGB. González-Gaya
B. González-Gaya
MIM. Irazola
M. Irazola
APA. Prieto
A. Prieto
NEN. Etxebarria
N. Etxebarria
OZO. Zuloaga
O. Zuloaga

29 July 2022 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Open access
PDF file
MMMikel Musatadi
Mikel Musatadi
CCClaudia Caballero
Claudia Caballero
LMLeire Mijangos
Leire Mijangos
APAilette Prieto
Ailette Prieto
MOMaitane Olivares
Maitane Olivares
OZOlatz Zuloaga
Olatz Zuloaga
In the present work, a target analysis method for simultaneously determining 24 diverse endocrine-disrupting compounds (EDCs) in urine (benzophenones, bisphenols, parabens, phthalates and antibacterials) was developed. The target analysis approach (including enzymatic hydrolysis, clean-up by solid-phase extraction and analysis by liquid chromatography coupled to tandem mass spectrometry (LC–MS/MS)) was optimized, validated and applied to volunteers’ samples, in which 67% of the target EDCs were quantified. For instance, benzophenone-3 (0.2–13 ng g−1), bisphenol A (7.7–13.7 ng g−1), methyl 3,5-dihydroxybenzoate (8–254 ng g−1), mono butyl phthalate (2–17 ng g−1) and triclosan (0.3–9 ng g−1) were found at the highest concentrations, but the presence of other analogues was detected as well. The developed target method was further extended to suspect and non-target screening (SNTS) by means of LC coupled to high-resolution MS/MS. First, well-defined workflows for SNTS were validated by applying the previously developed method to an extended list of compounds (83), and then, to the same real urine samples. From a list of approximately 4000 suspects, 33 were annotated at levels from 1 to 3, with food additives/ingredients and personal care products being the most abundant ones. In the non-target approach, the search was limited to molecules containing S, Cl and/or Br atoms, annotating 4 pharmaceuticals. The results from this study showed that the combination of the lower limits of detection of MS/MS and the identification power of high-resolution MS/MS is still compulsory for a more accurate definition of human exposome in urine samples. Graphical abstract

26 January 2021 in Separations
Verified
Journal Article
Open access
PDF file
MMMikel Musatadi
Mikel Musatadi
BGBelen Gonzalez-Gaya
Belen Gonzalez-Gaya
MIMireia Irazola
Mireia Irazola
ASAilette Prieto Sobrino
Ailette Prieto Sobrino
NENestor Etxebarria
Nestor Etxebarria
OZOlatz Zuloaga
Olatz Zuloaga
The development of suspect or non-target screening methods to detect xenobiotics in biological fluids is essential to properly understand the exposome and assess its adverse health effects on humans. In order to fulfil that aim, the biomonitorization of human fluids is compulsory. However, these methods are not yet extensively developed, especially for polar organic xenobiotics in biofluids such as milk, as most works are only focused on certain analytes of interest. In this work, a multi-target analysis method to determine 245 diverse xenobiotics in milk by means of Ultra High Performance Liquid Chromatography (UHPLC)-qOrbitrap was developed. Under optimal conditions, liquid milk samples were extracted with acetonitrile in the presence of anhydrous Na2SO4 and NaCl, and the extracts were cleaned-up by protein precipitation at low temperature and Captiva Non-Drip (ND)—Lipids filters. The optimized method was validated at two concentration-levels (10 ng/g and 40 ng/g) obtaining satisfactory figures of merit for more than 200 compounds. The validated multi-target method was applied to several milk samples, including commercial and breast milk, provided by 4 healthy volunteers. Moreover, the method was extended to perform suspect analysis of more than 17,000 xenobiotics. All in all, several diverse xenobiotics were detected, highlighting food additives (benzothiazole) or phytoestrogens (genistein and genistin) in commercial milk samples, and stimulants (caffeine), plasticizers (phthalates), UV filters (benzophenone), or pharmaceuticals (orlistat) in breast milk samples.

3 August 2023 in Chemosphere
Verified
Journal Article
Open access
MMMikel Musatadi
Mikel Musatadi
AAAsier Andrés-Maguregi
Asier Andrés-Maguregi
FAFrancesca De Angelis
Francesca De Angelis
APAilette Prieto
Ailette Prieto
EAEneritz Anakabe
Eneritz Anakabe
OZOlatz Zuloaga
Olatz Zuloaga
The use of suspect and non-target screening (SNTS) for the characterization of the chemical exposome employing human biofluids is gaining attention. Among the biofluids, urine is one of the preferred matrices since organic xenobiotics are excreted through it after metabolization. However, achieving a consensus between selectivity (i.e. preserving as many compounds as possible) and sensitivity (i.e. minimizing matrix effects by removing interferences) at the sample preparation step is challenging. Within this context, several sample preparation approaches, including solid-phase extraction (SPE), liquid-liquid extraction (LLE), salt-assisted LLE (SALLE) and dilute-and-shoot (DS) were tested to screen not only exogenous compounds in human urine but also their phase II metabolites using liquid-chromatography coupled to high-resolution tandem mass spectrometry (LC-HRMS/MS). Additionally, enzymatic hydrolysis of phase II metabolites was evaluated. Under optimal conditions, SPE resulted in the best sample preparation approach in terms of the number of detected xenobiotics and metabolites since 97.1% of the total annotated suspects were present in samples extracted by SPE. In LLE and SALLE, pure ethyl acetate turned out to be the best extractant but fewer suspects than with SPE (80.7%) were screened. Lastly, only 52.5% of the suspects were annotated in the DS approach, showing that it could only be used to detect compounds at high concentration levels. Using pure standards, the presence of diverse xenobiotics such as parabens, industrial chemicals (benzophenone-3, caprolactam and mono-2-ethyl-5-hydroxyhexyl phthalate) and chemicals related to daily habits (caffeine, cotinine or triclosan) was confirmed. Regarding enzymatic hydrolysis, only 10 parent compounds of the 44 glucuronides were successfully annotated in the hydrolysed samples. Therefore, the screening of metabolites in non-hydrolysed samples through SNTS is the most suitable approach for exposome characterization.

13 January 2024 in Chemosphere
Verified
Journal Article
Open access
MMMikel Musatadi
Mikel Musatadi
IBInés Baciero-Hernández
Inés Baciero-Hernández
APAilette Prieto
Ailette Prieto
MOMaitane Olivares
Maitane Olivares
NENestor Etxebarria
Nestor Etxebarria
OZOlatz Zuloaga
Olatz Zuloaga
Suspect and non-target screening (SNTS) methods are being promoted in order to decode the human exposome since a wide chemical space can be analysed in a diversity of human biofluids. However, SNTS approaches in the exposomics field are infra-studied in comparison to environmental or food monitoring studies. In this work, a comprehensive suspect screening workflow was developed to annotate exposome-related xenobiotics and phase II metabolites in diverse human biofluids. Precisely, human urine, breast milk, saliva and ovarian follicular fluid were employed as samples and analysed by means of ultra-high performance liquid chromatography coupled with high resolution tandem mass spectrometry (UHPLC-HRMS/MS). To automate the workflow, the "peak rating" parameter implemented in Compound Discoverer 3.3.2 was optimized to avoid time-consuming manual revision of chromatographic peaks. In addition, the presence of endogenous molecules that might interfere with the annotation of xenobiotics was carefully studied as the employment of inclusion and exclusion suspect lists. To evaluate the workflow, limits of identification (LOIs) and type I and II errors (i.e., false positives and negatives, respectively) were calculated in both standard solutions and spiked biofluids using 161 xenobiotics and 22 metabolites. For 80.3 % of the suspects, LOIs below 15 ng/mL were achieved. In terms of type I errors, only two cases were identified in standards and spiked samples. Regarding type II errors, the 7.7 % errors accounted in standards increased to 17.4 % in real samples. Lastly, the use of an inclusion list for endogens was favoured since it avoided 18.7 % of potential type I errors, while the exclusion list caused 7.2 % of type II errors despite making the annotation workflow less time-consuming.

12 September 2024 in Environmental Science & Technology
Verified
Journal Article
Closed access
LBLidia Belova
Lidia Belova
MMMikel Musatadi
Mikel Musatadi
CGCeline Gys
Celine Gys
MRMaarten Roggeman
Maarten Roggeman
FOFatima Den Ouden
Fatima Den Ouden
Adrian CovaciAdrian Covaci
Adrian Covaci